CClinicalTrials.gg
TerminatedNCT03048331FESUpdated Nov 26, 2025

Functional Electrical Stimulation (FES) and Reconstructive Tetraplegia Hand and Arm Surgery

An interventional study of Functional Electrical Stimulation in Spinal Cord Injury Cervical, sponsored by Swiss Paraplegic Research, Nottwil. Terminated at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-26.

Sponsored by Swiss Paraplegic Research, Nottwil · Not applicable, Interventional, and Treatment

Why this study was terminated
Inability to recruit further study participants
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

FES is a common and established method in the rehabilitation of persons with spinal cord injury (SCI). Some known effects of FES were investigated in several studies e.g. avoiding disuse and denervation atrophy, improving muscle force, power output and endurance changing muscle fibre type, increasing cross sectional area of muscle, increasing muscle mass, activation of nerve sprouting, reducing spasticity and motor learning.

Most of the studies investigated the impact of FES in the lower limbs. For the upper extremities fewer studies exist. However, it is supposed that the effects of FES are similar.

In the rehabilitation of persons with tetraplegia, FES, especially the stimulation of the upper extremities triggered by electromyography (EMG) is an established method to generally improve hand and arm function. However, none of those studies has investigated the effect of FES in combination with reconstructive tetraplegia hand surgery. Improved muscle strength is supposed to improve the functional outcome in participation. Additionally, FES could increase the motor learning process. Supported by the clinical observation we hypothesize that FES has a positive influence on the outcome of surgical reconstruction of tendon and/or nerve transfers.

Read the detailed description

In the rehabilitation of patients with a tetraplegia, FES is a common used method to improve the function of the arms and hands. The effects of FES also gain in importance considering the procedure of reconstructive arm and/or hand surgery in tetraplegic patients. The functioning of arm and hand muscles can be improved by surgically inverting intact muscles. Therefore, strengthening of the donor and recipient muscles with FES seems to be reasonable. So far it is not established if systematic training with FES before and after reconstructive hand and arm surgery could additionally improve the outcome in terms of strength, motor learning and function. However, clinical observations show a possible positive effect of FES.

The aim of the present randomized controlled study is to evaluate the use of FES before and after a reconstructive arm and/or hand surgery in order to increase the strength of the donor and recipient muscles, and thus, improving the result regarding strength and functionality.

A total of 30 tetraplegic patients who are planned to have a reconstructive arm and/or hand surgery at the Swiss Paraplegic Centre will be included into the study. The participating subjects will be randomized into two groups: a control and an intervention group.

The control group (15 patients) will receive defined standardized physio- and occupational therapy after the surgery. The intervention group (15 patients) will receive a combination of standardized physio- and occupational therapy and FES, before and after surgery. The standardized therapy will be supplemented with FES for 3 months, 3 x 30min per week.

To verify the effects of FES on muscular strength and functionality of the arms and hands, several assessments will be conducted at 4 different time points (T1: 12 weeks before surgery // T2: just before surgery // T3: 4 weeks post-surgery // T4: 16 weeks post-surgery). The course of the voluntary muscular strength and the strength generated by FES of both, the donor and the recipient muscle will be measured. In addition, the change in muscle volume in forearm and upper arm will be assessed by ultrasound. Furthermore, a standardized test to check several grasping action will be performed and there will also be a manual testing of the muscles in arms and hands.

Statistical analysis of these assessments enable an estimation of the benefit and effect of FES as an additional therapy in the context of reconstructive arm and/or hand surgery for tetraplegic patients.

02

Conditions studied

  • Spinal Cord Injury Cervical

Browse trials for

Keywords

  • Functional Electrical Stimulation
  • Tetraplegia
  • Reconstructive Hand Surgery
03

In context

Quadriplegia

189 studies on the registry are indexed under Quadriplegia; 72 are open to participants now.

This study's enrollment of 15 is above the median of 13 across 162 interventional studies indexed under Quadriplegia.

Browse Quadriplegia studies →

Lead sponsor

Swiss Paraplegic Research, Nottwil is the lead sponsor of 69 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • traumatic or non-traumatic (> 6 month) spinal cord injury
  • Age ≥ 18 years
  • Level of lesion C4 - Th1
  • American Spinal Cord Injury Association Impairment Scale (AIS) A/B/C/D
  • Planned reconstructive hand or arm surgery at the Swiss Paraplegic Centre Nottwil
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients during primary rehabilitation
  • Patients' inability to follow the study, e.g. mental-health problems, language problems, dementia etc.
  • Pregnancy (anamnestic)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Functional Electrical Stimulation

    Before surgery, the donor muscle is stimulated via surface electrodes in a loaded position or against resistance 3 times a week for 30 minutes. After surgery, the patients receive the same standard therapy as the control group. The electrical stimulation is performed once a day in combination with standard therapy for 30 minutes against gravity or resistance or in a loaded position.

    Device: Functional Electrical Stimulation

  • No intervention
    Standard therapy

    Postoperatively, 20 min passive and active movements of the hand or arm are applied manually by a therapist. Additionally, the patients actively perform the same exercises once a day for 20 min. The movements are based on a standardised post-surgical treatment protocol.

Interventions

  • DeviceFunctional Electrical Stimulation

    Functional electrical stimulation is applied with stimulators according to the lesion. In case of a upper motor neuron lesion the stimulation operates via nerve. For the stimulation surface electrodes are placed on the skin over the muscle belly. The stimulation of the innervated muscles will be conducted using the following conditions: 300-400 usec, 20-50 Hz, amplitude depends on the quality of muscle contraction (20-80 mA). the duty cycle of the stimulation is 3 sec. ramp up, 5 ec. plateau, 2 sec. ramp down, 10 sec. pause.

06

What researchers measure

Primary outcomes

  1. Change in evoked force

    Change in voluntary and electro-stimulated evoked force (torque Nm) for the recipient muscle

    Time frame: 12 weeks before surgery, 1 day before surgery, 4 weeks post-surgery and 16 weeks post-surgery

  2. Change in power output

    Change in voluntary and electro-stimulated power output (W) for the recipient muscle

    Time frame: 12 weeks before surgery, 1 day before surgery, 4 weeks post-surgery and 16 weeks post-surgery

Secondary outcomes

  1. Change in Canadian Occupational Performance Measurement (COPM)

    Changes of functional outcomes (i.e. performance and satisfaction) of the treated upper limb before and after surgery

    Time frame: 2 weeks before surgery, 1 day before surgery and 16 weeks post-surgery

  2. Change in muscle volume

    Difference in muscle volume of the treated limb before and after surgery measured by ultrasound

    Time frame: 2 weeks before surgery, 1 day before surgery and 16 weeks post-surgery

  3. Change in the treatment effectiveness

    Questionnaire of the participant's perception of the treatment effectiveness to evaluate the benefit of FES according to effort of the treatment

    Time frame: 2 weeks before surgery, 1 day before surgery and 16 weeks post-surgery

  4. Change in muscle activity

    Change in the muscle activity of a transferred muscle in a new function surface assessed by EMG

    Time frame: 4 weeks post-surgery and 16 weeks post-surgery

07

Study locations

1 site
  • Swiss Paraplegic Centre
    Nottwil, Canton of Lucerne 6207, Switzerland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03048331
Lead sponsor
Swiss Paraplegic Research, Nottwil
Responsible party
Sponsor
First posted
Feb 9, 2017
Start date
Mar 1, 2017
Primary completion
Nov 19, 2025
Completion
Nov 19, 2025
Last update
Nov 26, 2025

Study contacts

Jan Fridén, Prof. Dr. med.
principal investigator · Swiss Paraplegic Centre Nottwil, Switzerland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion